| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |